279 related articles for article (PubMed ID: 28819100)
21. How many podocyte autophagosomes are there in immunoglobulin A nephropathy and idiopathic membranous nephropathy?
Liang S; Jin J; Gong J; Lin B; Li Y; He Q
Int Urol Nephrol; 2016 Dec; 48(12):2109-2114. PubMed ID: 27580730
[TBL] [Abstract][Full Text] [Related]
22. Glomerular clusterin is associated with PKC-alpha/beta regulation and good outcome of membranous glomerulonephritis in humans.
Rastaldi MP; Candiano G; Musante L; Bruschi M; Armelloni S; Rimoldi L; Tardanico R; Sanna-Cherchi S; Ferrario F; Montinaro V; Haupt R; Parodi S; Carnevali ML; Allegri L; Camussi G; Gesualdo L; Scolari F; Ghiggeri GM
Kidney Int; 2006 Aug; 70(3):477-85. PubMed ID: 16775601
[TBL] [Abstract][Full Text] [Related]
23. Lipopolysaccharide-induced podocyte injury is mediated by suppression of autophagy.
Tan X; Chen Y; Liang X; Yu C; Lai Y; Zhang L; Zhao X; Zhang H; Lin T; Li R; Shi W
Mol Med Rep; 2016 Jul; 14(1):811-8. PubMed ID: 27221629
[TBL] [Abstract][Full Text] [Related]
24. Podocyte antigens and glomerular disease.
Ronco P; Debiec H
Nephron Exp Nephrol; 2007; 107(2):e41-6. PubMed ID: 17726340
[TBL] [Abstract][Full Text] [Related]
25. Podocytes that detach in experimental membranous nephropathy are viable.
Petermann AT; Krofft R; Blonski M; Hiromura K; Vaughn M; Pichler R; Griffin S; Wada T; Pippin J; Durvasula R; Shankland SJ
Kidney Int; 2003 Oct; 64(4):1222-31. PubMed ID: 12969140
[TBL] [Abstract][Full Text] [Related]
26. Immunohistochemical studies of vitronectin, C5b-9, and vitronectin receptor in membranous nephropathy.
Ogawa T; Yorioka N; Yamakido M
Nephron; 1994; 68(1):87-96. PubMed ID: 7527506
[TBL] [Abstract][Full Text] [Related]
27. The novel involvement of podocyte autophagic activity in the pathogenesis of lupus nephritis.
Jin J; Ye M; Zhao L; Zou W; Shen W; Zhang H; Gong J; He Q
Histol Histopathol; 2018 Aug; 33(8):803-814. PubMed ID: 29446059
[TBL] [Abstract][Full Text] [Related]
28. Renal C3 synthesis in idiopathic membranous nephropathy: correlation to urinary C5b-9 excretion.
Montinaro V; Lopez A; Monno R; Cappiello V; Manno C; Gesualdo L; Schena FP
Kidney Int; 2000 Jan; 57(1):137-46. PubMed ID: 10620195
[TBL] [Abstract][Full Text] [Related]
29. Autoimmunity in membranous nephropathy targets aldose reductase and SOD2.
Prunotto M; Carnevali ML; Candiano G; Murtas C; Bruschi M; Corradini E; Trivelli A; Magnasco A; Petretto A; Santucci L; Mattei S; Gatti R; Scolari F; Kador P; Allegri L; Ghiggeri GM
J Am Soc Nephrol; 2010 Mar; 21(3):507-19. PubMed ID: 20150532
[TBL] [Abstract][Full Text] [Related]
30. Ginsenoside-Rg1 protects podocytes from complement mediated injury.
Zhang MH; Fan JM; Xie XS; Deng YY; Chen YP; Zhen R; Li J; Cheng Y; Wen J
J Ethnopharmacol; 2011 Sep; 137(1):99-107. PubMed ID: 21600971
[TBL] [Abstract][Full Text] [Related]
31. Metformin combined with rapamycin ameliorates podocyte injury in idiopathic membranous nephropathy through the AMPK/mTOR signaling pathway.
Ma M; Pan Y; Zhang Y; Yang M; Xi Y; Lin B; Hao W; Liu J; Wu L; Liu Y; Qin X
J Cell Commun Signal; 2023 Dec; 17(4):1405-1415. PubMed ID: 37702819
[TBL] [Abstract][Full Text] [Related]
32. Down-regulation of the long non-coding RNA XIST ameliorates podocyte apoptosis in membranous nephropathy via the miR-217-TLR4 pathway.
Jin LW; Pan M; Ye HY; Zheng Y; Chen Y; Huang WW; Xu XY; Zheng SB
Exp Physiol; 2019 Feb; 104(2):220-230. PubMed ID: 30414341
[TBL] [Abstract][Full Text] [Related]
33. C5b-9 and adhesion molecules in human idiopathic membranous nephropathy.
Papagianni AA; Alexopoulos E; Leontsini M; Papadimitriou M
Nephrol Dial Transplant; 2002 Jan; 17(1):57-63. PubMed ID: 11773463
[TBL] [Abstract][Full Text] [Related]
34. Urinary C5b-9 excretion and clinical course in idiopathic human membranous nephropathy.
Kon SP; Coupes B; Short CD; Solomon LR; Raftery MJ; Mallick NP; Brenchley PE
Kidney Int; 1995 Dec; 48(6):1953-8. PubMed ID: 8587257
[TBL] [Abstract][Full Text] [Related]
35. Autophagy maturation associated with CD38-mediated regulation of lysosome function in mouse glomerular podocytes.
Xiong J; Xia M; Xu M; Zhang Y; Abais JM; Li G; Riebling CR; Ritter JK; Boini KM; Li PL
J Cell Mol Med; 2013 Dec; 17(12):1598-607. PubMed ID: 24238063
[TBL] [Abstract][Full Text] [Related]
36. The Intertwining of Autophagy and the Ubiquitin Proteasome System in Podocyte (Patho)Physiology.
Heintz L; Meyer-Schwesinger C
Cell Physiol Biochem; 2021 Sep; 55(S4):68-95. PubMed ID: 34523304
[TBL] [Abstract][Full Text] [Related]
37. Immunology of membranous nephropathy: from animal models to humans.
Sinico RA; Mezzina N; Trezzi B; Ghiggeri GM; Radice A
Clin Exp Immunol; 2016 Feb; 183(2):157-65. PubMed ID: 26459770
[TBL] [Abstract][Full Text] [Related]
38. Down-regulation of miR-186 contributes to podocytes apoptosis in membranous nephropathy.
Sha WG; Shen L; Zhou L; Xu DY; Lu GY
Biomed Pharmacother; 2015 Oct; 75():179-84. PubMed ID: 26382839
[TBL] [Abstract][Full Text] [Related]
39. Transcellular transport and membrane insertion of the C5b-9 membrane attack complex of complement by glomerular epithelial cells in experimental membranous nephropathy.
Kerjaschki D; Schulze M; Binder S; Kain R; Ojha PP; Susani M; Horvat R; Baker PJ; Couser WG
J Immunol; 1989 Jul; 143(2):546-52. PubMed ID: 2738403
[TBL] [Abstract][Full Text] [Related]
40. [Cordycepin protects podocytes from injury mediated by complements complex C5b-9].
Hong T; Cui LK; Wen J; Zhang MH; Fan JM
Sichuan Da Xue Xue Bao Yi Xue Ban; 2015 Mar; 46(2):173-8, 227. PubMed ID: 25924424
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
